Literature DB >> 19912993

Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells.

Hui Yang1, Nathan Bushue, Pengli Bu, Yu-Jui Yvonne Wan.   

Abstract

Fenretinide, a synthetic retinoid, is known to induce apoptosis in various cancer cells. However, the mechanism by which fenretinide induces apoptosis remains unclear. The current study examines the mechanisms of fenretinide-induced apoptosis in human hepatoma cells. The induction of Nur77 and the cytoplasmic distribution of Nur77 induced by fenretinide were positively correlated with the apoptotic effect of fenretinide in HCC cells. The sensitivity of Huh-7 cells was related to Nur77 translocation and targeting mitochondria, whereas the mechanism of resistance for HepG2 cells seemed due to Nur77 accumulating in the nucleus. The intracellular location of Nur77 was also associated with the differential capability of fenretinide-induced ROS generation in these two cell lines. In addition, the knockdown of Nur77 expression by siRNA greatly reduced fenretinide-induced apoptosis and cleaved caspase 3 in Huh-7 cells. Therefore, our findings demonstrate that fenretinide-induced apoptosis of HCC cells is Nur77 dependent and that the intracellular localization of Nur77 dictates the sensitivity of the HCC cells to fenretinide-induced apoptosis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19912993      PMCID: PMC2832928          DOI: 10.1016/j.bcp.2009.11.004

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  32 in total

1.  Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.

Authors:  B J Maurer; L Melton; C Billups; M C Cabot; C P Reynolds
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

2.  Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.

Authors:  S Y Sun; W Li; P Yue; S M Lippman; W K Hong; R Lotan
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

3.  Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells.

Authors:  Guo-quan Chen; Bingzhen Lin; Marcia I Dawson; Xiao-kun Zhang
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

4.  Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?

Authors:  Carsten-Henning Ohlmann; Christine Jung; Gabriele Jaques
Journal:  Int J Cancer       Date:  2002-08-10       Impact factor: 7.396

5.  Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.

Authors:  Hongtao Wang; Anthony G Charles; Aaron J Frankel; Myles C Cabot
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

6.  The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.

Authors:  Patricia Boya; Maria Celia Morales; Rosa-Ana Gonzalez-Polo; Karine Andreau; Isabelle Gourdier; Jean-Luc Perfettini; Nathanael Larochette; Aurélien Deniaud; Fanny Baran-Marszak; Remy Fagard; Jean Feuillard; Aintzane Asumendi; Martine Raphael; Bernard Pau; Catherine Brenner; Guido Kroemer
Journal:  Oncogene       Date:  2003-09-18       Impact factor: 9.867

7.  N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species.

Authors:  Hiroaki Goto; Hiroyuki Takahashi; Hisaki Fujii; Koichiro Ikuta; Shumpei Yokota
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

Review 8.  Nuclear retinoid receptors and the transcription of retinoid-target genes.

Authors:  Julie Bastien; Cécile Rochette-Egly
Journal:  Gene       Date:  2004-03-17       Impact factor: 3.688

9.  Growth and DNA damage-inducible transcription factor 153 mediates apoptosis in response to fenretinide but not synergy between fenretinide and chemotherapeutic drugs in neuroblastoma.

Authors:  Marco Corazzari; Penny E Lovat; Serafina Oliverio; Andy D J Pearson; Mauro Piacentini; Christopher P F Redfern
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

10.  Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.

Authors:  Bingzhen Lin; Siva Kumar Kolluri; Feng Lin; Wen Liu; Young-Hoon Han; Xihua Cao; Marcia I Dawson; John C Reed; Xiao-kun Zhang
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

View more
  15 in total

Review 1.  Retinoid pathway and cancer therapeutics.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  Adv Drug Deliv Rev       Date:  2010-08-03       Impact factor: 15.470

Review 2.  Targeting NR4A1 (TR3) in cancer cells and tumors.

Authors:  Syng-Ook Lee; Xi Li; Shaheen Khan; Stephen Safe
Journal:  Expert Opin Ther Targets       Date:  2011-01-05       Impact factor: 6.902

3.  Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors.

Authors:  Hui Yang; Qi Zhan; Yu-Jui Yvonne Wan
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

4.  Positive end-expiratory pressure and surfactant decrease lung injury during initiation of ventilation in fetal sheep.

Authors:  Noah H Hillman; Ilias Nitsos; Clare Berry; J Jane Pillow; Suhas G Kallapur; Alan H Jobe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-19       Impact factor: 5.464

Review 5.  The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer.

Authors:  Jordan A Beard; Alexa Tenga; Taosheng Chen
Journal:  Cell Signal       Date:  2014-11-15       Impact factor: 4.315

6.  ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cells.

Authors:  Hui Yang; Yuqiang Nie; Yuyuan Li; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2011-01-15       Impact factor: 5.858

Review 7.  Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule.

Authors:  Rosa Luisa Potenza; Pietro Lodeserto; Isabella Orienti
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

8.  Transcriptome profiling and genome-wide DNA binding define the differential role of fenretinide and all-trans RA in regulating the death and survival of human hepatocellular carcinoma Huh7 cells.

Authors:  Ying Hu; Hui-Xin Liu; Yuqi He; Yaping Fang; Jianwen Fang; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2013-02-08       Impact factor: 5.858

9.  Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells.

Authors:  Hui Yang; Yun Zhong; Hui Xie; Xiaobo Lai; Miqing Xu; Yuqiang Nie; Shiming Liu; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2013-05-01       Impact factor: 5.858

10.  NFAT1 C-terminal domains are necessary but not sufficient for inducing cell death.

Authors:  Douglas V Faget; Pedro I Lucena; Bruno K Robbs; João P B Viola
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.